Numerous studies have demonstrated elevated mTOR activity in db/db mice, streptozotocin (STZ)-induced diabetic rats, and DKD patients (Sakai et al., 2019; Song et al., 2019). This evidence concerns the gene MTOR and diabetic kidney disease.